JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER
|
|
- Verity Hensley
- 6 years ago
- Views:
Transcription
1 JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER
2 SAFE HARBOR STATEMENT Certain statements made during the course of this presentation may not be purely historical and consequently may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to statements made regarding: our partner model and the ability of our partners and installed base to drive future growth; the ability of our technology to enhance productivity and efficiency; our financial position and long-term revenue growth; our molecular diagnostic business model, the markets we are targeting, market segmentation, expected growth of such markets, and the ability of our products to address those markets; sales of our products, their technical capabilities, and the anticipated market size and acceptance, demand and regulatory environment and approvals therefor; our direct sales efforts; our system placements; our system and assay product pipeline and anticipated timelines for regulatory approvals and market releases, including for ARIES instrumentation and assays; market opportunity for ARIES and NxTAG RPP product; functionality and benefits of ARIES and NxTAG RPP and competitive position; reimbursement trends; development and growth of our PGx strategy, our ability to drive growth through investment in R&D and focus on operating leverage and managing operating costs; our long term financial targets; our key steps and strategies for growth; our strategic outlook and growth plan for our business for 2015 and beyond; operational trends, including those related to sales of systems, assays, consumables, and royalty revenues; competitive threats and products offered by other companies; 2014 revenue guidance; our business outlook, financial targets and projections about revenues, cash flow, system shipments, expenses and market conditions, and their anticipated impact on Luminex for 2015 and beyond; and, any statements of the plans, strategies and objectives of management for future operations. These forward looking statements speak only as of the date hereof and are based on our current beliefs and expectations and are subject to known or unknown risks and uncertainties some of which are beyond our control that could cause actual results or plans to differ materially and adversely from those anticipated in the forward looking statements. Factors that could cause or contribute to such differences are detailed in our annual, quarterly, or other filings with the Securities and Exchange Commission. We undertake no obligation to update these forward looking statements. Also, certain non-gaap financial measures as defined by SEC Regulation G, may be covered in this presentation. To the extent that any non-gaap financial measures are covered, a presentation of and reconciliation to the most directly comparable GAAP financial measures will be included in this presentation may be available on our website at in accordance with Regulation G. 2 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
3 OUR BUSINESS A Foundation Built on Multiplexing - From only one sample, detect and identify up to 500 biological agents - Improves time, cost, and productivity - Distributed by key industry players Growing Focus on Molecular Diagnostics - Expanding product portfolio with the launch of new, innovative products - Moving downstream into large, adjacent markets - Direct salesforce Partnership Channel LMNX Direct Sales Channel Shifting the Company Accelerating into the a Diagnostics Transformation Business into a Diagnostics Business 3 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
4 PARTNERSHIP CHANNEL FUNDING GROWTH IN MOLECULAR CHANNEL $(M) CAGR = 5% [1] Stable, Strong & Profitable Partnership Channel Revenue: ~$117M 50-1Q15 Royalty Revenue: ~$11M (+6% Y/Y) Systems Consumables Royalties - Growth Expectations: mid-single digits - Annualized end-user sales approaching $500M for 2015 $(M) CAGR = 28% [1] Molecular Diagnostics Drives Future Growth Revenue: ~$88M (+18% Y/Y) - 1Q15 Revenue: ~$25M (+17% Y/Y) Assays - Significant growth in PGx and infectious disease portfolio - On Track for ~$100M+ in Assays in 2015 [1] 4-year CAGR based on 2014 revenue over Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
5 POSITIONED FOR ACCELERATING GROWTH DIFFERENTIATED Technology Solution-based product innovation to Lab customers ATTRACTIVE Markets Leadership position in growing multibillion dollar markets with multiple revenue streams NEW PRODUCT Launches NxTAG RPP ARIES FINANCIAL Leverage Strong gross margins & profitability 5 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
6 THE ESTABLISHED LEADER IN MULTIPLEX TESTING 11,200+ Instruments placed 700+ Assays Developed Detect and identify up to 500 biological agents Save time Decrease cost Increase productivity 65 IVDs Clearances on Luminex Technology 325+ Issued Patents Worldwide More than 22,000 published scientific studies cite Luminex technology and/or partner products 6 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
7 NXTAG RPP TIMELINE PROGRESSING TOWARDS COMMERCIAL LAUNCH Started Clinical Trials FDA 510(k) Submission 1Q15 2Q15 Summer 15E 4Q15E RUO Launched Target Date for FDA Clearance 7 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
8 NXTAG RESPIRATORY PATHOGEN PANEL (RPP) SCALABLE SOLUTION FOR STREAMLINED RESPIRATORY TESTING Challenges for Labs Many pathogens present with similar symptoms Labs are busy and may be understaffed Require quick results, even during peak seasons Post-PCR contamination can cause false results Seasonal demand NxTAG Solution Single-well assay, 22 pathogens, comprehensive coverage Simplified workflow, minimal hands-on time Results on up to 96 samples in ~4 hours Closed-tube workflow reduces contamination risk Scalable throughput: from 1-96 samples at a time 8 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
9 ARIES TIMELINE ADVANCING TOWARDS COMMERCIAL LAUNCH Completed Development FDA 510(k) Submission/ RUO Launch Commercial Launch 5+ Assays Cleared 20 systems placed across 10 customer sites 2H14 1Q15 Summer 15E 4Q15E 2Q16E ~20 systems placed across 10 customer sites Started Clinical Trials HSV 1/2 Completed C. Diff Ongoing Target Date for FDA Clearance 9 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
10 ARIES : SOLUTION-BASED PRODUCT INNOVATION Challenges for Labs Contamination and Misdiagnosis Varying Testing Platforms Scarcity of Personnel (i.e. Lab Technicians) High Volume of Reports Limited Bench Space ARIES Solution Sample-to-Answer, Minimizes User Error Compelling Menu Strategy (i.e. Rapid Menu Expansion) True Walkaway Capability Streamlined Reporting Minimal Footprint 15 Bench Space 10 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
11 LUMINEX CURRENT MDx PORTFOLIO INFECTIOUS DISEASES GENETICS Portfolio Performance 2014: ~$88M (+18% Y/Y) 1Q15: ~$25M (+17% Y/Y) On Track for ~$100M+ in 2015 MARKETS Respiratory Gastrointestinal PRODUCTS xtag RVP xtag RVP Fast xtag GPP Women s Health MultiCode HSV 1/2 Source: Market Diagnostics International (MDxi), 2013 EMMES and internal estimates PRODUCTS Total Addressable Market = ~500M 11 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science MARKETS Pharmacogenetics (Personalized Medicine) Cystic Fibrosis PRODUCTS xtag CYP2D6 xtag CYP2C19 xtag CF
12 INCREMENTAL MARKET OPPORTUNITY EXPANDING DOWNSTREAM WITH ARIES Luminex 2015 and Beyond A R I E S xtag NxTAG Full MDx (500) Moderately Complex MDx (1000) Limited MDx (5,000) Current MDx TAM: ~$500M MDx TAM with ARIES: $1.5B+ Key Positioning Access to Attractive, Fast Growing Markets Segments Simple, Easy to Use Solutions Drive Adoption Offering Complete Testing Solution: - xtag / NxTAG RPP (High Multiplex) - ARIES (Real-time PCR) No MDx Capability (7,000) Source: Mdxi Market Diagnostics Int l, 2013 Emmes: 1,000 U.S. laboratory survey, Scientia Analysis, AHA Registered U.S. Hospitals, CMS CLIA 12 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
13 ARIES COMMERCIAL LAUNCH PROGRESS REGULATORY Initiated HSV and C. Diff Clinical Trials On track for FDA submission in Summer 15 SALESFORCE EXPANSION ~10 Additional Headcount Goal: Strategically position for maximum coverage Integrated salesforce CUSTOMER ENGAGEMENT Early Access Program Clinical Whitepapers Time in Motion studies Engaging with KOL s SCALE UP OPERATIONS Invested in semiautomation equipment R&D resource allocation 13 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
14 ARIES VISION FOR THE FUTURE LEVERAGING OUR MULTIPLEXING HERITAGE Additional Plex Capabilities ARIES Menu Expansion Multiplexing & RT-PCR Building a Platform for Sustainable Growth 14 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
15 CONSISTENT TOP-LINE GROWTH Total Revenue ($M) Expectation above mid-point of range Guidance of $230M - $236M [2] E [1] 5-year CAGR based on mid-point of 2015 guidance range over 2010 [2] 2015 revenue guidance as of 1Q15 earnings call, May 4, Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
16 STRONG GROSS AND OPERATING MARGINS Gross Margin: 68% 68% 70% 67% 70% 70% Non-GAAP Operating Margin [1] 20% 16% 12% 8% 4% Highlights Industry Leading Gross Margins Significant Operating Leverage & Profitability - 1Q15 EPS: $0.18 Strong Free Cash Flow - No Debt - ~$111M in Cash and Investments at March 31, % Q15 YTD [1] Non-GAAP Operating margin for years exclude litigation fees, restructuring, severance, and settlement of distributor agreements 16 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
17 EXCITING FUTURE AHEAD Utilize brand recognition and reputation while expanding addressable market Offer a complete testing solution Focus on execution, organizational synergy and becoming market driven Leverage a strong balance sheet Growing emphasis on diagnostics 17 Copyright 2015 Luminex Corporation Breakthrough solutions to improve health and advance science
18 THANK YOU
35th Annual J.P. Morgan Healthcare Conference
35th Annual J.P. Morgan Healthcare Conference Investor Presentation Nachum Homi Shamir President and Chief Executive Officer January, 2017 Safe Harbor Statement Certain statements made during the course
More informationCalix Q Financial Results. February 13, 2018
Calix Q4 2017 Financial Results February 13, 2018 Safe Harbor This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements
More informationWESCO International. Dave Schulz, Senior Vice President and Chief Financial Officer Raymond James 39 th Annual Investors Conference, March 7, 2018
WESCO International Dave Schulz, Senior Vice President and Chief Financial Officer 2 Safe Harbor Statement All statements made herein that are not historical facts should be considered as forward-looking
More informationSupplemental Financial Schedules May 19, 2015
Supplemental Financial Schedules May 19, 2015 The presentations and related schedules contain financial measures that are not calculated in accordance with generally accepted accounting principles (GAAP).
More informationSecurities Analyst Meeting 2017 PRINTING. Enrique Lores President, Imaging and Printing Business
Securities Analyst Meeting 2017 PRINTING Enrique Lores President, Imaging and Printing Business Forward-looking statements Today s presentations contain forward-looking statements that involve risks, uncertainties
More informationirobot First-Quarter 2017 Conference Call Script
irobot First-Quarter 2017 Conference Call Script Operator: Good day everyone and welcome to the irobot first-quarter 2017 financial results conference call. This call is being recorded. At this time for
More informationERI INVESTOR PRESENTATION
ERI INVESTOR PRESENTATION (NASDAQ: ERII) Jefferies Energy Conference 2016 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the Safe Harbor provisions of the Private
More information30 th Annual JP Morgan Healthcare Conference January 10, Carl Hull, Chairman and CEO Herm Rosenman, SVP and CFO
An Innovative Growth Company in Molecular Diagnostics 30 th Annual JP Morgan Healthcare Conference January 10, 2012 Carl Hull, Chairman and CEO Herm Rosenman, SVP and CFO Safe Harbor Statement Any statements
More informationGenMark Diagnostics TRANSFORMING MULTIPLEX MOLECULAR TESTING. J.P. Morgan Healthcare Conference 2018
GenMark Diagnostics TRANSFORMING MULTIPLEX MOLECULAR TESTING J.P. Morgan Healthcare Conference 2018 1 Forward-Looking Statements This presentation contains forward-looking statements about GenMark Diagnostics,
More informationLEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS
LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS SAFE HARBOR STATEMENT This presentation contains forward-looking statements that are based
More informationTecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA
Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA Safe Habor Statement All statements in this presentation not referring to historical
More informationKeysight Technologies Investor Presentation. December 2017
Keysight Technologies Investor Presentation December 2017 Page 1 Safe Harbor This communication contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the
More informationLuc Gregoire Chief Financial Officer. Drexel Hamilton Annual Telecom, Media and Technology Conference September 6, 2017
Luc Gregoire Chief Financial Officer Drexel Hamilton Annual Telecom, Media and Technology Conference September 6, 2017 Forward Looking Statements This presentation and oral statements made from time to
More informationMorgan Stanley Conference. November 15, 2017
Morgan Stanley Conference November 15, 2017 1 Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections,
More informationRefrigerants, Recycling & Energy Efficiency
Refrigerants, Recycling & Energy Efficiency NASDAQ: HDSN 1 Investor Presentation: August 2017 Safe Harbor Statement Statements contained herein, which are not historical facts constitute forwardlooking
More informationJP Morgan Global Healthcare Conference
JP Morgan Global Healthcare Conference January 12, 2016 Robert Friel, Chairman and CEO Factors affecting future performance & non-gaap financial measures This presentation contains "forward-looking" statements
More informationUBS Global Life Sciences Conference
September 20, 2011 UBS Global Life Sciences Conference Tecan Group AG Dr. Rudolf Eugster, CFO September 20, 2011 / p2 / UBS GLSC Contents Introducing Tecan Strategic Growth Drivers Financials H1 2011 &
More informationMorgan Stanley 2017 Global Consumer and Retail Conference
Morgan Stanley 2017 Global Consumer and Retail Conference David Hatfield President, Chief Executive Officer and Chairman of the Board November 14, 2017 Page 1 Forward-Looking Statements Unless the context
More informationStericycle, Inc. Q NASDAQ: SRCL
Stericycle, Inc. Q1 2015 NASDAQ: SRCL Forward - Looking Statements This presentation may contain forward-looking statements that involve a number of risks and uncertainties and our actual results could
More informationSecond Quarter 2015 Earnings Conference Call Prepared Remarks August 5th, 2015
Second Quarter 2015 Earnings Conferen nce Call Prepared Remarks August 5th, 2015 Mark McKechnie: Thank you. Welcome to our second quarter 2015 earnings call. With me on the call today are Scott Lang, our
More informationMonotype. Investor Update September 2017
Monotype Investor Update September 2017 1 Safe Harbor This presentation contains forward-looking statements, including those related to our investment thesis, including scale and expansion, the growth
More informationMr. Lou Panaccio Executive Chairman
Mr. Lou Panaccio Executive Chairman 1 Overview Objective Develop compelling multiplexed test solutions for the $4BN global molecular diagnostic testing industry using our silica bead based AmpaSand technology
More informationA Leading Global Health Care Group
A Leading Global Health Care Group Roadshow Copenhagen October 6, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.
More informationExtreme Networks Acquisition of Zebra WLAN/Formerly Motorola Solutions. September 14, Extreme Networks, Inc. All rights reserved
Extreme Networks Acquisition of Zebra WLAN/Formerly Motorola Solutions September 14, 2016 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company
More informationFinancial Objectives. Forward Looking Statements. Symantec 2012 Financial Analyst Day 5/24/2012. James Beer. EVP & Chief Financial Officer
Financial Objectives James Beer EVP & Chief Financial Officer 1 Forward Looking Statements This presentation contains statements regarding our projected financial and business results, which may be considered
More informationChristine Skold. Vice President, Investor Relations and Corporate Communications
Christine Skold Vice President, Investor Relations and Corporate Communications 2 Safe Harbor Statement The Company claims the protection of the safe-harbor for forward-looking statements contained in
More informationBLUEPRINT 2021: RAISING EXPECTATIONS
9 January 2018 BLUEPRINT 2021: RAISING EXPECTATIONS Mark D. Morelli President and Chief Executive Officer Gregory P. Rustowicz Vice President Finance & Chief Financial Officer SAFE HARBOR STATEMENT These
More informationTractor Supply Company. Third Quarter 2015
Tractor Supply Company Third Quarter 2015 Safe Harbor Statement The Company claims the protection of the safe-harbor for forward-looking statements contained in the Private Securities Litigation Reform
More informationUsing LDTs to streamline CDx development. Dr Bob Holt Companion Diagnostic Development Manager
Using LDTs to streamline CDx development Dr Bob Holt Companion Diagnostic Development Manager Disclaimer This presentation contains my personal views and research and does not necessarily reflect the policies
More informationGood day, ladies and gentlemen. Welcome to today s conference call to discuss Stratasys third quarter 2017 financial results.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 SSYS Q3 2017 Earnings Script SLIDE 1 & 2: TITLE SLIDES SPEAKER:
More informationA full-service CRO with integrated early-stage capabilities
CHARLES RIVER TO ACQUIRE ARGENTA and BIOFOCUS A full-service CRO with integrated early-stage capabilities James C. Foster Chairman, President & CEO Thomas F. Ackerman Executive Vice President & CFO March
More informationINVESTOR PRESENTATION. February 2018
INVESTOR PRESENTATION February 2018 Forward Looking Statement Disclaimer This presentation contains statements, including statements about future plans and expectations, which constitute forward-looking
More informationLA-Z-BOY INCORPORATED
LA-Z-BOY INCORPORATED November 2017 Providing comfort to America for 90 years FORWARD-LOOKING DISCLAIMER This presentation contains forward-looking statements that involve uncertainties and risks as detailed
More informationQIAGEN Sample & Assay Technologies From Discovery to Patient
QIAGEN From Discovery to Patient New York, February 14 QIAGEN 2008 Analyst & Investor Day Peer Schatz, CEO -7- Forward Looking Statements Safe Harbor Statement: Certain of the statements contained in this
More informationWILLIAM BLAIR GROWTH STOCK CONFERENCE. June 14, 2017
WILLIAM BLAIR GROWTH STOCK CONFERENCE June 14, 2017 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and are subject
More informationInvestor Presentation
Investor Presentation 2017 www.enzo.com LEGAL DISCLAIMER Except for historical information, the matters discussed herein may be considered "forward looking" statements within the meaning of Section 27A
More informationRefrigerants, Recycling & Energy Efficiency
Refrigerants, Recycling & Energy Efficiency NASDAQ: HDSN 1 Investor Presentation: May 2017 Safe Harbor Statement Statements contained herein, which are not historical facts constitute forwardlooking statements,
More informationBrightcove Inc. Investor Presentation. May 2017
Brightcove Inc. Investor Presentation May 2017 Safe Harbor Statement These slides and the accompanying oral presentation contain certain forward-looking statements" within the meaning of the Private Securities
More informationSecond Quarter 2017 Earnings Teleconference. August 1, 2017
Second Quarter 2017 Earnings Teleconference August 1, 2017 Introduction Chuck Triano Senior Vice President, Investor Relations Forward-Looking Statements and Non-GAAP Financial Information 3 Our discussions
More informationInvestor Presentation Value Creation Plan
Investor Presentation Value Creation Plan March 7, 2018 Safe Harbor Statements This presentation is dated as of March 7, 2018 and speaks as of that date. Forward-Looking Statements This presentation contains
More informationCB&I Investor Presentation March 2017
A World of Solutions CB&I Investor Presentation March 2017 A Leading Provider of Technology and Infrastructure for the Energy Industry Safe Harbor Statement This presentation contains forward-looking statements
More informationAvery Dennison Investor Presentation August 2014
Avery Dennison Investor Presentation August 2014 Unless otherwise indicated, the discussion of the company s results is focused on its continuing operations, and comparisons are to the same period in the
More informationInvestor Presentation. November 26, 2013
Investor Presentation November 26, 2013 Forward-Looking Statements This presentation may contain forward-looking statements as defined under U.S. federal securities laws. These statements reflect management's
More informationTRUSTED IDENTITIES TRUSTED DEVICES TRUSTED TRANSACTIONS. Investor Presentation - December 2017
TRUSTED IDENTITIES TRUSTED DEVICES TRUSTED TRANSACTIONS Investor Presentation - December 2017 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 21E
More informationWESTFALIA AUTOMOTIVE ACQUISITION AUGUST 25, 2016
WESTFALIA AUTOMOTIVE ACQUISITION AUGUST 25, 2016 1 SAFE HARBOR STATEMENT FORWARD-LOOKING STATEMENTS This presentation may contain "forward-looking statements" as defined in the Private Securities Litigation
More informationAccelerating our strategy: GSK to acquire full ownership of Consumer Healthcare Business
Accelerating our strategy: GSK to acquire full ownership of Consumer Healthcare Business Buyout of Novartis stake Strategic review of Horlicks and other Consumer Healthcare Nutrition products Cautionary
More informationUBS Media Conference Neil Berkett, Acting CEO 5 December 2007
UBS Media Conference Neil Berkett, Acting CEO 5 December 2007 Forward-looking statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Various statements contained in
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference Align Technology, Inc. Shirley Stacy, VP Investor Relations and Corporate Communications June 3, 2014 2014 Align Technology, Inc. All rights reserved. 1 2014 Align Technology,
More informationFINANCIAL PERSPECTIVES
FINANCIAL PERSPECTIVES M³ - Meet Merck Management Marcus Kuhnert, CFO Darmstadt December 10, 2015 Disclaimer Cautionary Note Regarding Forward-Looking Statements This communication may include forward-looking
More informationTriNet Group, Inc. Investor Presentation November 2017
TriNet Group, Inc. Investor Presentation November 2017 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements that are not
More informationAirgain A leading provider of advanced antenna technologies
Airgain A leading provider of advanced antenna technologies Investor presentation September 2017 Important caution regarding forward looking statements This presentation contains forward-looking statements.
More informationAdobe Investor Presentation
Adobe Investor Presentation October, 2017 Financial Disclaimer Some of the information discussed in this presentation contains forward-looking statements that involve risk and uncertainty. Actual results
More informationKraft Foods. Q Results. May 6, 2010
Kraft Foods Q1 2010 Results May 6, 2010 Forward-looking statements This slide presentation contains a number of forward-looking statements. Words such as expects, goals, plans, believes, continues, may,
More informationDedicated to Molecular Diagnostics
Dedicated to Molecular Diagnostics For Europe Sample & Assay Technologies QIAGEN s growing role in molecular diagnostics At QIAGEN, one of our key goals is to support clinical decision-making and improve
More information16th Annual ICR XChange Conference January 14, 2014
16th Annual ICR XChange Conference January 14, 2014 Bill DeLaney President, Chief Executive Officer Chris Kreidler Executive Vice President, Chief Financial Officer Forward-Looking Statements Statements
More informationNon Deal Roadshow - Europe
Non Deal Roadshow - Europe 2015 May Analyst Meeting February/March 2016 The world leader in serving science The world leader in serving science Non-GAAP Measures This presentation contains certain financial
More informationTriNet Group, Inc. William Blair Growth Company Conference June 2017
TriNet Group, Inc. William Blair Growth Company Conference June 2017 Disclaimer Cautionary Note Regarding Forward-Looking Statements and Other Financial Information This presentation contains statements
More informationBemis Company, Inc. KeyBanc Capital Markets Basic Materials & Packaging Conference
Bemis Company, Inc. KeyBanc Capital Markets Basic Materials & Packaging Conference September 14, 2011 Safe Harbor Statement This presentation includes forward-looking statements within the meaning of the
More informationFinancial targets breakdown Cost saving actions
Financial targets breakdown Cost saving actions Capital markets day 2017 N O V E M B E R 7-8, 2 0 1 7 N E W Y O R K Ericsson Internal 2017-10-06 Page 1 Carl Mellander CFO Ericsson Internal 2017-10-06 Page
More informationGrowth Plan. October 29, 2014
Growth Plan October 29, 2014 Safe Harbour Statement This presentation contains forward-looking statements, which express the current beliefs and expectations of management. Such statements are based on
More informationHewlett Packard Enterprise SEC Form 10 Filing
Hewlett Packard Enterprise SEC Form 10 Filing Investor Presentation July 1, 2015 Forward looking statements This presentation contains forward-looking statements within the meaning of the safe harbor provisions
More informationSecond Quarter 2016 Financial Results. August 4, 2016
Second Quarter 2016 Financial Results August 4, 2016 Cautionary Note Regarding Forward-Looking Statements This presentation and various remarks we make during this presentation contain forward-looking
More informationHow to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations. The complete guide to developing or expanding your lab
How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations The complete guide to developing or expanding your lab Includes step-by-step plans for basic and full-service MDx
More informationAgios Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationCOMPANY OVERVIEW JOHN MORIKIS CHAIRMAN, PRESIDENT & CHIEF EXECUTIVE OFFICER FINANCIAL COMMUNITY PRESENTATION OCTOBER 3, 2017
COMPANY OVERVIEW JOHN MORIKIS CHAIRMAN, PRESIDENT & CHIEF EXECUTIVE OFFICER Forward Looking Statement The presentations today will contain certain forward looking statements," as defined under U.S. federal
More informationAmdocs Limited Reports Revenue Growth of 19.4% in Third Quarter
Amdocs Limited Reports Revenue Growth of 19.4% in Third Quarter Key highlights: Revenue of $450.2 million, in line with guidance Sequential revenue growth of 1.7% Proforma EPS increases 30.4% to $0.30,
More informationBruker drives profitable growth by enabling breakthrough discoveries & development of new applications that improve the quality of human life
Bruker drives profitable growth by enabling breakthrough discoveries & development of new applications that improve the quality of human life Innovation with Integrity BRUKER CORPORATION Safe Harbor Statement
More informationPhilips: a focused leader in HealthTech
Philips: a focused leader in HealthTech Frans van Houten, CEO Royal Philips 36th Annual J.P. Morgan Healthcare Conference, San Francisco, USA January 9, 2018 Important information Forward looking statements
More information1 st Quarter 2007 Earnings. April 19, 2007
1 st Quarter 2007 Earnings April 19, 2007 Forward-Looking Statement The statements in this presentation that are not historical facts are forward-looking statements based on current expectations of future
More informationInvestor Presentation Doug Bryant, President & CEO
Investor Presentation Doug Bryant, President & CEO Forward-looking statements This presentation contains forward-looking statements within the meaning of the federal securities laws that involve material
More informationInnovations in Molecular Lab Operation. Joseph M. Campos, PhD, D(ABMM), F(AAM)
Innovations in Molecular Lab Operation Lessons in the Best Ways to Blend Automation, Lean Workflow, and Paperless Processes Joseph M. Campos, PhD, D(ABMM), F(AAM) Interim Chief, Division of Laboratory
More informationARRIS Announces Acquisition of BigBand Networks. Building Leadership in Video Networking October 11, 2011
ARRIS Announces Acquisition of BigBand Networks Building Leadership in Video Networking Safe Harbor This presentation contains forward looking statements. These statements include, among others, accelerating
More informationJefferies London Healthcare Conference Julie Brown, CFO
Jefferies London Healthcare Conference Julie Brown, CFO Forward looking statements This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding
More informationTSYS to Acquire Cayan
TSYS to Acquire Cayan Solidifying TSYS Leadership Position in Technology-Led SMB Merchant Services December 18, 2017 Forward Looking Statements This slide presentation and comments made by management contain
More informationThe In Vitro Diagnostic CRO
The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro
More informationFedEx Corporation Investor Relations February 12, 2018
FedEx Corporation Investor Relations February 12, 2018 Forward-Looking Statements Certain statements in this presentation may be considered forward-looking statements, such as statements relating to management
More informationKeyBanc Conference. June 2016
KeyBanc Conference June 2016 Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. Any forward looking statements contained herein, including those relating
More informationenabling a connected world through open telecom solutions Investor Overview March 2018
enabling a connected world through open telecom solutions Investor Overview March 2018 Safe Harbor Statement This presentation contains forward-looking statements, including the Company s outlook. Radisys
More informationSoftware. George Kadifa Executive Vice President HP Software
Software George Kadifa Executive Vice President HP Software Executive summary HP Software s strategy is to enable the New Style of IT FY13 focus on building strong leadership and improved execution Transitioning
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More informationTalend Investor Relations Presentation August 25, 2016
Talend Investor Relations Presentation August 25, 2016 2016 Talend SA 1 This presentation and the accompanying oral presentation contain forward-looking statements. All statements other than statements
More informationA LEADING GLOBAL HEALTH CARE GROUP. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY
A LEADING GLOBAL HEALTH CARE GROUP Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements
More informationMay 2013 NASDAQ: HSKA Heska Corporation. All Rights Reserved.
May 2013 NASDAQ: HSKA 2013 Heska Corporation. All Rights Reserved. NASDAQ: HSKA Forward-Looking Statements This presentation may contain forward-looking statements within the meaning of the Private Securities
More informationCapturing the HealthTech opportunity
Capturing the HealthTech opportunity Frans van Houten, CEO Royal Philips JP Morgan European Capital Goods Conference June 11, 2015 Philips: strong starting positions in health and well-being Businesses
More informationSAP Capital Markets Day. March 6, 2018
SAP Capital Markets Day March 6, 2018 Agenda 01:00 01:05 pm Welcome Stefan Gruber, Head of Investor Relations 01:05 01:35 pm Strategy and Vision: Opportunity in Time of Disruption Bill McDermott, CEO Moderated
More informationFirst Quarter FY18 First Fiscal Quarter Financial Results FY18 Financial Results May 31, 2017
First Quarter FY18 First Fiscal Quarter Financial Results FY18 Financial Results May 31, 2017 Put a date here. Or May the speaker s 31, 2017 name. Or their @handle Forward-Looking Statements and Non-GAAP
More informationPharmaceutical Product Development NASDAQ: PPDI. Dan Darazsdi Chief Financial Officer. Credit Suisse Healthcare Conference November 2009
Pharmaceutical Product Development NASDAQ: PPDI Dan Darazsdi Chief Financial Officer Credit Suisse Healthcare Conference 2009 12 November 2009 Safe Harbor Except for historical information, all of the
More informationUpdate on External Presentation of Non-GAAP Results July 29, 2016
Update on External Presentation of Non-GAAP Results July 29, 2016 Safe Harbor Disclosure These materials may include forward-looking statements regarding future events with respect to Activision Blizzard,
More informationPegasystems Inc. Build for Change Pegasystems Inc.
Pegasystems Inc. Build for Change 11 2013 Pegasystems Inc. Safe Harbor Certain statements contained in this presentation may be construed as forward-looking statements as defined in the Private Securities
More informationEnabling Wireless Infrastructure Solutions. Brian Bronson, President & CEO May 9, 2013
Enabling Wireless Infrastructure Solutions Brian Bronson, President & CEO May 9, 2013 Safe Harbor & Non-GAAP Measures Safe Harbor Statement This presentation contains forward-looking statements, including
More information2017 Annual Meeting of Shareholders
2017 Annual Meeting of Shareholders May 17, 2017 The world leader in serving science Safe Harbor / Non-GAAP Measures Various remarks that we may make in the following presentations about the company s
More informationSmart Connected Services
Smart Connected Services Investor Presentation I n f o r m a t i o n a s o f N o v e m b e r 2 8, 2 0 1 7 Safe Harbor Statement This presentation contains forward-looking statements. In particular, statements
More informationDeutsche Bank 2006 High Yield Conference
Deutsche Bank 2006 High Yield Conference October 4, 2006 Dave Meyers CFO 1 Forward-looking Statement Disclaimer During the course of our discussion today, we will make statements that may constitute projections,
More informationNew Cardinal Health (Post-Spin)
New Cardinal Health (Post-Spin) George Barrett Vice Chairman and Chief Executive Officer Healthcare Supply Chain Services and Chief Executive Officer Cardinal Health, Inc. (post-spin) January 14, 2009
More informationCapital Market Day June 12, 2012
Capital Market Day 2012 June 12, 2012 Product Segments IV Drugs John Ducker Member of the Management Board President Region North America Capital Market Day Fresenius Kabi, June 12, 2012 Agenda 1 2 3 4
More informationRoyal Philips Electronics. Alan Cathcart Senior Vice President
Royal Philips Electronics Alan Cathcart Senior Vice President Forward Looking Statements Forward Looking Statements This document contains certain forward-looking statements with respect to the financial
More informationFrom Resilience To Growth:
From Resilience To Growth: Mapping a New Direction for Life Sciences & Medical Devices Attorney Advertising Prior results do not guarantee a similar outcome Models used are not Mapping the Way: Opportunities
More information